Federated Hermes’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.6K Sell
809
-22
-3% -$1.93K ﹤0.01% 1666
2026
Q1
$75.1K Sell
831
-14
-2% -$1.28K ﹤0.01% 1630
2025
Q4
$76K Sell
845
-653
-44% -$61.9K ﹤0.01% 1602
2025
Q3
$148K Sell
1,498
-634
-30% -$62.8K ﹤0.01% 1536
2025
Q2
$194K Buy
2,132
+1,202
+129% +$116K ﹤0.01% 1503
2025
Q1
$105K Buy
930
+194
+26% +$20.8K ﹤0.01% 1579
2024
Q4
$77.7K Sell
736
-229
-24% -$24.6K ﹤0.01% 1595
2024
Q3
$104K Sell
965
-145,990
-99% -$15.9M ﹤0.01% 1567
2024
Q2
$15.9M Sell
146,955
-84,639
-37% -$9.98M 0.04% 443
2024
Q1
$30.6M Sell
231,594
-1,191
-0.5% -$149K 0.07% 327
2023
Q4
$28.3M Buy
232,785
+17,545
+8% +$1.96M 0.07% 307
2023
Q3
$24.2M Buy
215,240
+33,405
+18% +$4.24M 0.06% 321
2023
Q2
$26.5M Sell
181,835
-882
-0.5% -$120K 0.07% 319
2023
Q1
$23.6M Sell
182,717
-26,045
-12% -$3.27M 0.06% 345
2022
Q4
$26.6M Sell
208,762
-1,476
-0.7% -$171K 0.07% 316
2022
Q3
$22M Buy
210,238
+32,995
+19% +$3.62M 0.06% 358
2022
Q2
$18.6M Buy
177,243
+14,797
+9% +$1.76M 0.05% 404
2022
Q1
$20.8M Buy
162,446
+6,065
+4% +$731K 0.05% 429
2021
Q4
$19.3M Sell
156,381
-21,950
-12% -$2.87M 0.04% 493
2021
Q3
$25.3M Buy
178,331
+7,743
+5% +$1.14M 0.05% 427
2021
Q2
$26.6M Sell
170,588
-30,611
-15% -$4.96M 0.05% 415
2021
Q1
$31.3M Sell
201,199
-32,582
-14% -$5.05M 0.06% 383
2020
Q4
$35M Buy
233,781
+135,103
+137% +$19.1M 0.07% 322
2020
Q3
$13M Buy
98,678
+17,491
+22% +$2.28M 0.03% 508
2020
Q2
$9.41M Buy
81,187
+55,183
+212% +$6.36M 0.02% 560
2020
Q1
$2.55M Sell
26,004
-5,680
-18% -$745K 0.01% 817
2019
Q4
$4.6M Buy
31,684
+20,305
+178% +$2.8M 0.01% 796
2019
Q3
$1.52M Sell
11,379
-1,016
-8% -$131K ﹤0.01% 1132
2019
Q2
$1.42M Sell
12,395
-301
-2% -$35.3K ﹤0.01% 1180
2019
Q1
$1.57M Sell
12,696
-50,114
-80% -$5.69M ﹤0.01% 1144
2018
Q4
$6.32M Sell
62,810
-15,766
-20% -$1.77M 0.02% 669
2018
Q3
$10M Buy
78,576
+1,685
+2% +$200K 0.02% 567
2018
Q2
$8.32M Buy
76,891
+726
+1% +$79K 0.02% 522
2018
Q1
$8.06M Buy
76,165
+70,756
+1,308% +$8.22M 0.02% 490
2017
Q4
$633K Sell
5,409
-114,430
-95% -$12.9M ﹤0.01% 1331
2017
Q3
$13.6M Sell
119,839
-127,091
-51% -$14.7M 0.04% 342
2017
Q2
$30.8M Sell
246,930
-162,365
-40% -$19.2M 0.09% 201
2017
Q1
$48.5M Buy
409,295
+2,872
+0.7% +$326K 0.14% 136
2016
Q4
$40.7M Buy
406,423
+292,453
+257% +$31.3M 0.12% 147
2016
Q3
$14.4M Buy
113,970
+109,454
+2,424% +$13.5M 0.04% 344
2016
Q2
$528K Buy
4,516
+219
+5% +$24.8K ﹤0.01% 1264
2016
Q1
$445K Buy
4,297
+1,956
+84% +$189K ﹤0.01% 1310
2015
Q4
$233K Sell
2,341
-227
-9% -$22.2K ﹤0.01% 1452
2015
Q3
$234K Sell
2,568
-224
-8% -$22.5K ﹤0.01% 1471
2015
Q2
$296K Sell
2,792
-2,303
-45% -$255K ﹤0.01% 1440
2015
Q1
$581K Buy
5,095
+2,072
+69% +$236K ﹤0.01% 1325
2014
Q4
$333K Sell
3,023
-2,163
-42% -$228K ﹤0.01% 1427
2014
Q3
$506K Sell
5,186
-76
-1% -$7.47K ﹤0.01% 1356
2014
Q2
$531K Sell
5,262
-27,798
-84% -$2.71M ﹤0.01% 1337
2014
Q1
$3.04M Sell
33,060
-2,386
-7% -$220K 0.01% 801
2013
Q4
$3.21M Sell
35,446
-3,012
-8% -$261K 0.01% 765
2013
Q3
$3.07M Sell
38,458
-27
-0.1% -$2.13K 0.01% 757
2013
Q2
$2.8M Buy
+38,485
New +$2.88M 0.01% 763

Other funds holding ZBH

Federated Hermes's ZBH Position: Q2 2026 in Review

Federated Hermes reduced its Zimmer Biomet (ZBH) stake by 2.6% in Q2 2026, selling an estimated $1.93K and leaving 809 shares worth $69.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Federated Hermes first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $48.5M in Q1 2017. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Federated Hermes held 809 shares of Zimmer Biomet worth $69.6K as of Q2 2026.
  • Federated Hermes sold 22 Zimmer Biomet shares in Q2 2026, an estimated $1.93K.
  • Zimmer Biomet made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1666 holding.
  • Federated Hermes first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Federated Hermes's Zimmer Biomet position peaked at $48.5M in Q1 2017.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.